Dacryocystitis of Infancy*

Cassady, J. V.

doi:10.1016/0002-9394(48)91535-9

Cited by 64 publications

(18 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Including stillborns, 70% of neonates present with CNDO at delivery (Cassady 1952). However, only 6–20% of all neonates have symptoms of CNDO (Guerary & Kendig 1948; Young & MacEwen 1997) because the obstruction usually resolves spontaneously before lacrimal secretion begins (Cassady 1948).…”

Section: Treatment Of Cndo During the First Year Of Lifementioning

confidence: 99%

See 1 more Smart Citation

Management of congenital nasolacrimal duct obstruction

Takahashi

Kakizaki

Chan

et al. 2010

Acta Ophthalmologica

View full text Add to dashboard Cite

ABSTRACT.Our review aims to provide an update of management protocols for congenital nasolacrimal duct obstruction (CNDO). Although early probing performed before the age of 1 year was traditionally recommended, many reports have since confirmed high frequencies of spontaneous resolution during the first year of life. Accordingly, a 'wait-and-see' approach, combined with conservative therapies, is judged to be the best option in infants aged < 1 year. By contrast, persistent obstruction beyond 1 year of age warrants probing as a firstline interventional therapy. However, the optimal timing for probing remains controversial. Although there remains a high possibility of spontaneous resolution after the first year of age, this must be balanced against the decrease in success rates for probing that accompanies advancing age. If conservative management fails, persistent CNDO beyond 1 year of age should be managed either by further observation or by primary probing according to the severity of symptoms. In patients in whom probing fails, advanced treatment such as balloon catheter dilation, silicone tube intubation or dacryocystorhinostomy may be considered.

show abstract

Section: Treatment Of Cndo During the First Year Of Lifementioning

confidence: 99%

“…Probing has traditionally been advocated as first‐line management of CNDO (Cassady 1948, 1952; Koke 1950; Broggi 1959; Ffooks 1962; Pollard 1979; Baker 1985; Robb 1985, 1986; Stager et al. 1992; Paul & Shepherd 1994; Stevens 1998).…”

Section: Treatment Of Cndo During the First Year Of Lifementioning

confidence: 99%

Management of congenital nasolacrimal duct obstruction

Takahashi

Kakizaki

Chan

et al. 2010

Acta Ophthalmologica

View full text Add to dashboard Cite

show abstract

“…Congenital nasolacrimal duct obstruction is a condition that occurs commonly in infants22-25 and usually resolves with conservative management alone24-20. It is the most common cause of epiphora in infants 1,2 70% of neonates present with congenital nasolacrimal duct obstructions at delivery 3 with only 6-20% being symptomatic 4,5 as the obstruction usually resolves before lacrimal secretion begins. 6 The common approach in the management of this condition is lacrimal massage and observation with or without topical antibiotic treatment as most cases of nasolacrimal duct obstruction resolve without surgery.…”

Section: Introductionmentioning

confidence: 99%

“…6,13 Other conditions which may present with epiphora need to be excluded including epiblepharon, congenital entropion, congenital glaucoma, keratitis and uveitis. 5 The fluorescent dye disappearance test is a non invasive test that can confirm nasolacrimal duct obstruction with 90% sensitivity8. Down's syndrome and craniofacial malformations may be associated with a higher prevalence of congenital nasolacrimal duct obstruction which can be confirmed with imaging.…”

Section: Introductionmentioning

confidence: 99%

Pediatric nasolacrimal duct obstruction a review of current management

Aziz

Lee

Alnahrawy

et al. 2019

AOVS

View full text Add to dashboard Cite

show abstract

“…Congenital nasolacrimal duct obstruction resulting in congenital dacrocystitis is present in 2% to 6% of newborns, however it resolves in the first 3 of 4 weeks in most of the infants [1][2][3][4]. Congenital dacryocystitis is due to delayed canalization of fibrous layer of the nasal mucoperiosteum and imperforate membrane, valve of Hasner at the lower end of the nasolacrimal duct.…”

Section: Introductionmentioning

confidence: 99%

Congenital Dacryocystitis- Clinical Profile and Outcome

Kumar

Dubey

Borasi³

et al. 2018

Trop J Ophthalmol Otolaryngol

View full text Add to dashboard Cite

Aim:To assess the clinical and epidemiological profile of congenital dacryocystis and its treatment outcome. Material and Methods: A prospective study was conducted for duration of two years, cases with congenital dacryocystitis of age less than 5 years were included. A detailed history was taken giving emphasis to epiphora onset, duration, treatment and resolution. Ocular examination was done along with regurgitation on pressure over lacrimal sac test. The plan for the management was standard stepwise approach according to age groups and clinical condition of the cases. The conservative treatment included sac massage and surgical procedure were probing and syringing and endonasal dacryocystorhinostomy. Follow-up was done for 6 months and final clinical assessment was done to assess the success of procedure. Results: Total 65 eyes of 51 cases were included in the study. Mean age of presentation was-14.6 ± 2.3 months with 52.9% females. Unilateral involvement was more common. Epiphora was most common complaint with 63% ROPLAS positive. The success rate of sac massage was 81% and the overall success rate for treatment of congenital dacryocystitis was 96%. Conclusion: Congenital dacryocystitis is a common pediatric problem. Treatment of congenital dacryocystitis should be started as early as possible and in stepwise manner initially conservative than surgical.

show abstract

Dacryocystitis of Infancy*

Cited by 64 publications

References 0 publications

Management of congenital nasolacrimal duct obstruction

Management of congenital nasolacrimal duct obstruction

Pediatric nasolacrimal duct obstruction a review of current management

Congenital Dacryocystitis- Clinical Profile and Outcome

Contact Info

Product

Resources

About